Catharina Ziekenhuis

Running trials

• Not yet recruiting

  AI Analysis of CT Scans to Classify Ovarian Tumours as Benign, Borderline or Malignant Before Surgery

  NCT07883551· Source

• Active, not recruiting

  Investigating the Impact of Nudging Cardiologists to Prescribe Class I Recommendations Foundational- and Additional Medical Therapy in Heart Failure Patients

  NCT06844006· Source

• Recruiting

  A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned

  NCT07665450· Phase 3· Source

• Not yet recruiting

  Endoscopic (EID) Versus Surgical (TAMIS) Local Excision for Early Stage Rectal Cancer

  NCT07846046· Source

• Recruiting

  Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer

  NCT07645625· Phase 4· Source

• Recruiting

  NO Re-excision MelanomA - NORMA 2

  NCT07530887· Phase 3· Source

• Recruiting

  Accuracy and Sustainability of SCALE-EYE Evaluation for Measuring Reliable Polyp Size

  NCT07005453· Source

• Active, not recruiting

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· Phase 3· Source

• Recruiting

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· Phase 3· Source

• Recruiting

  OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating Lymphocytes

  NCT06476119· Source

• Recruiting

  A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease

  NCT07363044· Source

• Enrolling by invitation

  Efficacy of Endothelin Receptor Antagonism in Coronary Artery Spasm

  NCT06432452· Phase 2/3· Source

• Recruiting

  Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study

  NCT06785740· Source

• Active, not recruiting

  BIO|MASTER.CSP Study

  NCT06620237· Source

• Active, not recruiting

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· Phase 3· Source

• Recruiting

  Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer

  NCT05180864· Source

• Recruiting

  Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer

  NCT07260435· Phase 3· Source

• Recruiting

  The Effect of exeRcise And Diet on Quality of Life in Patients With Incurable Cancer of Esophagus and Stomach (RADICES)

  NCT06138223· Source

• Active, not recruiting

  Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System

  NCT05501873· Source

• Recruiting

  The (Cost-)Effectiveness of Surgical Excision of Colorectal Endometriosis Compared to ART Treatment Trajectory

  NCT05677269· Source

• Recruiting

  Observational Dutch Young Symptomatic StrokE studY - nEXT

  NCT05853796· Source

• Recruiting

  National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)

  NCT05326620· Source

• Recruiting

  EMR Versus ESD for Barrett's Neoplasia

  NCT05276791· Source

• Recruiting

  Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

  NCT05640999· Phase 2· Source

• Recruiting

  INSIGHTFUL-FFR Clinical Trial

  NCT05437900· Phase 4· Source

• Active, not recruiting

  Evolut™ EXPAND TAVR II Pivotal Trial

  NCT05149755· Source

• Active, not recruiting

  Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28)

  NCT04597671· Phase 3· Source

• Recruiting

  DIStal gastriC Bypass OUtcome in Revision SurgEry After Roux-en-y Gastric Bypass

  NCT04894838· Source

• Recruiting

  Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer Outcome

  NCT04754672· Source

• Enrolling by invitation

  Stop Ovarian Cancer Young; Effect of the Opportunistic Salpingectomy on Age of Menopause

  NCT04757922· Source

• Active, not recruiting

  Pullback Pressure Gradient (PPG) Global Registry

  NCT04789317· Source

• Enrolling by invitation

  The NetherLands Registry of Invasive Coronary Vasomotor Function Testing (NL-CFT)

  NCT06083155· Source

• Recruiting

  TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

  NCT04294927· Source

• Active, not recruiting

  Defining the Potency of DTG/3TC for Suppressed HIV Patients in Real-life: the DUALING Study

  NCT04707326· Source

• Active, not recruiting

  PeRcutaneous cOronary Intervention of Native Coronary arTery Versus Venous Bypass Graft in Patients With Prior CABG

  NCT03805048· Source

• Active, not recruiting

  Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)

  NCT03448835· Phase 2· Source

• Recruiting

  S-FLEX Netherlands Registry: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System

  NCT03443999· Source

• Recruiting

  BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis

  NCT03549416· Source

• Active, not recruiting

  Multicentric Randomised Trial for Resectable Gastric Cancer

  NCT02931890· Phase 2· Source

• Active, not recruiting

  Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

  NCT03425838· Phase 3· Source

• Recruiting

  Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer

  NCT03026140· Phase 2· Source

• Active, not recruiting

  Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy

  NCT02284308· Source

• Active, not recruiting

  A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients

  NCT02301286· Phase 3· Source

• Recruiting

  Prospective Data Collection Initiative on Colorectal Cancer

  NCT02070146· Source

• Active, not recruiting

  Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial

  NCT01558921· Phase 3· Source

• Active, not recruiting

  Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

  NCT00005584· Phase 3· Source

• Active, not recruiting

  RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

  NCT00002462· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer5 recruiting
• Coronary artery disease4 recruiting
• Gastric and esophageal cancer3 recruiting
• Ovarian cancer3 recruiting
• Obesity2 recruiting
• Stroke2 recruiting
• Atopic dermatitis (eczema)1 recruiting
• Cervical cancer1 recruiting
• Childhood cancers1 recruiting
• Crohn's disease1 recruiting
• Endometrial cancer1 recruiting
• Endometriosis1 recruiting
• Heart failure1 recruiting
• Kidney cancer1 recruiting
• Melanoma1 recruiting
• Multiple myeloma1 recruiting
• Prostate cancer1 recruiting
• Triple-negative breast cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Non-invasive Prediction of Fluid and Noradrenaline Responsiveness Using the Carotid Wave Intensity.

  NCT06197321· Source

• Completed

  Dual Hormone Closed Loop in Type 1 Diabetes

  NCT05669547· Source

• Completed

  A Clinical Trial to Assess the Elixir Medical LithiX Coronary Hertzian Contact Intravascular Lithotripsy Catheter

  NCT05828173· Source

• Completed

  FAME II-10-year Follow-Up

  NCT06159231· Source

• Recruiting

  High-Risk prostatE Cancer radiatiOn Versus surgERy

  NCT05931419· Source

• Completed

  A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome

  NCT06734117· Source

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Source

• Completed

  Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%

  NCT04435626· Phase 3· Source

• Completed

  A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice

  NCT03782207· Source

• Completed

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· Phase 3· Source